| Name | Walmart Pharmacy 10-1745 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 3601 E Main St, Richmond, Indiana 47374 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (765) 935-9078 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In the first study of its kind, researchers found patients with S. aureus skin and soft tissue infections took, on average, just 57% of their prescribed antibiotic doses after leaving the hospital, resulting in nearly half of them getting a new infection or needing additional treatment for the existing skin infection.
SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced results of a 230 patient Phase 2 proof-of-concept study evaluating topical SAR 1118 ophthalmic solution in the treatment of aqueous deficient dry eye (keratoconjunctivitis sicca).
The recession has dealt a significant blow to New Jersey hospitals, with a new report showing that the statewide 2008 hospital operating margin reached just 0.2 percent, the lowest point since 1999.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.
› Verified 1 days ago
| NPI Number | 1760409981 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WAL-MART PHARMACY 10-1745 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3601 E Main St, Richmond, IN 47374 |
| Phone Number | 765-935-9078 |
News Archive
In the first study of its kind, researchers found patients with S. aureus skin and soft tissue infections took, on average, just 57% of their prescribed antibiotic doses after leaving the hospital, resulting in nearly half of them getting a new infection or needing additional treatment for the existing skin infection.
SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced results of a 230 patient Phase 2 proof-of-concept study evaluating topical SAR 1118 ophthalmic solution in the treatment of aqueous deficient dry eye (keratoconjunctivitis sicca).
The recession has dealt a significant blow to New Jersey hospitals, with a new report showing that the statewide 2008 hospital operating margin reached just 0.2 percent, the lowest point since 1999.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.
› Verified 1 days ago
News Archive
In the first study of its kind, researchers found patients with S. aureus skin and soft tissue infections took, on average, just 57% of their prescribed antibiotic doses after leaving the hospital, resulting in nearly half of them getting a new infection or needing additional treatment for the existing skin infection.
SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced results of a 230 patient Phase 2 proof-of-concept study evaluating topical SAR 1118 ophthalmic solution in the treatment of aqueous deficient dry eye (keratoconjunctivitis sicca).
The recession has dealt a significant blow to New Jersey hospitals, with a new report showing that the statewide 2008 hospital operating margin reached just 0.2 percent, the lowest point since 1999.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.
› Verified 1 days ago
Cates Family Eyecare Type: Medicare Supplier Location: 2001 Chester Blvd, Richmond, Indiana 47374 Phone: (765) 966-0583 | |
Dasco Home Medical Equipment Type: Medicare Supplier Location: 32 S 8th St, Richmond, Indiana 47374 Phone: (765) 983-3083 | |
Drs Reising & Burkhart Type: Medicare Supplier Location: 1900 East Main St, Richmond, Indiana 47374 Phone: (765) 962-2243 | |
Drs. Logan And Bailey, Optometrists Type: Medicare Supplier Location: 2517 E Main St, Richmond, Indiana 47374 Phone: (765) 966-2661 | |
Opti Vision 2020 Type: Medicare Supplier Location: 832 E Main St, Richmond, Indiana 47374 Phone: (765) 935-1808 |